Related Experiment Video
Updated: May 21, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Morphine Dependence Vaccines: Advances, Challenges, and Future Directions.
Manvir Singh Dadwal1, Jonaid Ahmad Malik1, Javed Naim Agrewala1
1Immunology Laboratory, Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar, Punjab, 140001, India.
Current Pharmaceutical Biotechnology
|May 20, 2026
Summary
Novel treatments for morphine dependence, including vaccines and nanotechnology, show promise in preclinical studies. These strategies aim to reduce morphine
Area of Science:
- Neuroscience and Pharmacology
- Immunology
- Biotechnology
Background:
- Morphine is widely used for pain relief but can lead to dependence, tolerance, and addiction.
- Existing treatments like naloxone, naltrexone, and buprenorphine help manage dependence.
- Adverse effects include sleep disturbances and gastrointestinal issues, with overdose risks similar to dependence.
Purpose of the Study:
- To review and analyze the latest advancements in treating morphine dependence.
- To explore novel therapeutic strategies beyond traditional anti-dependence medications.
- To provide an updated perspective on the mechanisms and effectiveness of emerging treatments.
Main Methods:
- Review of vaccine-based immunotherapies targeting morphine.
- Analysis of nanotechnology-enhanced drug delivery systems.
- Examination of gene-regulatory techniques, including DARPP-32 modulation.
- Inclusion of computational models of receptors.
Main Results:
- Vaccine designs (e.g., TLR-targeted, multivalent) generate anti-morphine antibodies and immune memory.
- Nanoparticle-enhanced therapies and gold nanorod gene delivery show potential.
- Gene modulation (e.g., DARPP-32) and TLR-targeted therapy diminish morphine's effects and alter reward signaling.
- Preclinical data indicate significant promise for these novel approaches.
Conclusions:
- Emerging therapies like immunotherapies and nanotechnology offer promising avenues for morphine dependence treatment.
- These strategies modulate key brain pathways and reduce the rewarding effects of morphine.
- While clinical trials are pending, preclinical results warrant further investigation for therapeutic application.
More Related Videos
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.